Akasi Pharma ApS — Credit Rating and Financial Key Figures

Akasi Pharma ApS (CVR number: 45364577) is a company from KØBENHAVN. The company reported a net sales of 1 mDKK in 2025. The operating profit percentage was poor at -158.1 % (EBIT: -1.6 mDKK), while net earnings were -1626.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -40 %, which can be considered poor and Return on Equity (ROE) was -65.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -38.7 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Akasi Pharma ApS's liquidity measured by quick ratio was 43.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.